October 11, 2023 Sophia Vida
Breaking News

SELLAS Advances Blood Cancer Treatment with “Tremendous Therapeutic Promise”

October 11, 2023 SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) has reported two significant milestones this week as it pursues development of its drug candidate, SLS009 for hematological malignancies. “SLS009 is a novel and highly selective CDK9 inhibitor which, to date, has shown tremendous therapeutic promise across multiple blood cancers.” Angelos Stergiou, MD, ScD h.c., … Continue reading “SELLAS Advances Blood Cancer Treatment with “Tremendous Therapeutic Promise””